Clinical Trial

A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
A Long-Term Extension Study for Participants Previously Treated with EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-01-23; most recent amendment 2026-07-16.
Trial Details
NCT Number NCT05708677
Lead Sponsor Abeona Therapeutics, Inc
Conditions RDEB
Enrollment 22 participants
Start Date 2021-02-09
Primary Completion 2036-02 (estimated)
Study Completion 2036-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-17